WATER FOR INJECTION EUROSPITAL

Italy

It is used as a solvent and diluent for the preparation of solutions, dilutions, or suspensions of medicinal products for injection or other sterile preparations.

Brand name WATER FOR INJECTION EUROSPITAL
Dosage form solution for infusion
Active substance / Dosage
Prescription type Non-prescription – not available over the counter
ATC code
Registration number 033122
Manufacturer EUROSPITAL S.P.A.
WATER FOR INJECTION EUROSPITAL solution for infusion

Frequently asked questions

How should Eurospital Water for Injections be used?

It must be used immediately after opening the container. Before use, the water must appear clear, colorless, free of visible particles, and a vacuum must be present in the vial.

What are the risks associated with continuous administration?

Continuous administration may cause excessive water accumulation (fluid overload), congestion, and a reduction in blood salt levels. In particular, continuous administration without the addition of potassium may cause a decrease in blood potassium levels (hypokalemia).

Are there any special warnings for those who are pregnant or breastfeeding?

Since this product acts as a vehicle for various medicinal products, it is necessary to consult the package leaflet of the specific medicinal product intended for administration to obtain information on use during pregnancy or breastfeeding.

What are the side effects of Eurospital Water for Injections?

As it is a vehicle for other drugs, to know any potential adverse effects, it is necessary to consult the package leaflet of the medicinal product being prepared with this solvent.

How should the product be stored?

The medicinal product must be stored in tightly closed containers at a temperature not exceeding 30°C and must not be refrigerated. It must be kept out of the sight and reach of children.

Instructions for use

Package leaflet: Information for the user

Water for Injections Eurospital 500 ml solvent for parenteral use

“Equivalent medicinal product”
Please read this leaflet carefully before using this medicine because it contains important information for you.
Always use this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse has instructed you.

  • Keep this leaflet. You may need to read it again.
  • If you need more information or advice, consult your pharmacist.
  • If any side effects occur, including those not listed in this leaflet, consult your doctor, pharmacist or nurse. See section 4.
  • Consult your doctor if you do not notice any improvement or if your symptoms worsen.

Contents of this leaflet:

  1. What Acqua per preparazioni iniettabili Eurospital is and what it is used for
  2. What you need to know before using Acqua per preparazioni iniettabili Eurospital
  3. How to use Acqua per preparazioni iniettabili Eurospital
  4. Possible side effects
  5. How to store Acqua per preparazioni iniettabili Eurospital
  6. Contents of the pack and other information

1. What Acqua per preparazioni iniettabili Eurospital is and what it is used for

Acqua per preparazioni iniettabili Eurospital belongs to the category of solvents and diluents and is indicated for
the preparation of medicinal solutions for injection.

2. What you need to know before using Water for Injections Eurospital

Do not use Water for Injections Eurospital
Water for Injections is a vehicle for various medicinal products; therefore, consult the package leaflet of the medicine you intend to administer.

Warnings and precautions
Talk to your doctor, pharmacist, or nurse before using Water for Injections Eurospital.
Prolonged administration may cause excessive water accumulation (fluid overload), congestion (congestive state), and reduced levels of salts in the blood; prolonged administration without potassium supplementation may lead to decreased potassium levels in the blood (hypokalaemia).
This is a generic medicine manufactured according to the requirements of the Pharmacopoeia.
Water for Injections is a vehicle for various medicinal products; therefore, for further information regarding its use (precautions, drug interactions, adverse effects), consult the package leaflet of the medicine you intend to administer.

Other medicines and Water for Injections Eurospital
Inform your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Water for Injections is a vehicle for various medicinal products; therefore, if you are taking other medicines, consult the package leaflet of the medicine you intend to administer.

Pregnancy and breastfeeding
If you are pregnant, suspect you may be pregnant, planning to become pregnant, or are breastfeeding, ask your doctor or pharmacist for advice before using this medicine.
Water for Injections is a vehicle for various medicinal products; therefore, consult the package leaflet of the medicine you intend to administer for information on use during pregnancy and breastfeeding.

Driving and using machines
Not applicable

3. How to use Water for Injections Eurospital

Use this medicine exactly as stated in this leaflet or as instructed by your doctor, pharmacist, or nurse. If you have any doubts, consult your doctor, pharmacist, or nurse.
You must use this medicine for preparing solutions, dilutions, or extemporaneous suspensions of injectable medicines or other sterile preparations.
Use this medicine immediately after opening the container.
The water must be clear, colourless, free from visible particles, and the vacuum must be present.
To check for the presence of vacuum, insert the vial adapter while the vial is inverted: bubbling will be observed.
Any unused residue must not be used.
If you have any doubts about how to use this medicine, consult your doctor, pharmacist, or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody will experience them.
Water for injections is a vehicle for various medicinal products; therefore, please consult the package leaflet of the medicine you intend to administer for information on side effects.

Reporting of side effects
If you experience any side effect, including those not listed in this leaflet, talk to your doctor, pharmacist or nurse.
You can also report side effects directly via the national reporting system at www.agenziafarmaco.gov.it/it/responsabili.
By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Water for Injections Preparations Eurospital

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after "Exp.". The expiry date refers to the product in its original, undamaged packaging, correctly stored.
The expiry date refers to the last day of that month.
Store in tightly closed containers.
Do not store above 30°C.
Do not refrigerate.
Do not use this medicine if you notice that the solution is not clear, colourless, free from visible particles, or if vacuum is absent.
Do not dispose of any medicine via wastewater or household waste. Ask your pharmacist how to dispose of medicines you no longer use. This will help protect the environment.

6. Contents of the pack and other information

What Acqua per preparazioni iniettabili Eurospital contains

  • The active substance is water for injections. 500 ml of solvent contains 500 ml of water for injections.

Description of the appearance of Acqua per preparazioni iniettabili Eurospital and contents of the pack
Solvent for parenteral use in a 500 ml vial.
Marketing Authorization Holder
Eurospital S.p.A., via Flavia, 122 – Trieste.
Manufacturers
Bieffe Medital S.p.A., via Nuova Provinciale snc – 23034 Grosotto (SO)
Laboratorios Grifols S.A. – Pol. Ind. Autopista – Passeig Fluvial 24 – 08150 Parets del Valles –
Barcelona – Spain.

Similar drugs

Brand name Dosage form Active substance / Dosage Manufacturer
WATER FOR INJECTIONS DIACO solution for infusion DIACO BIOFARMACEUTICI S.R.L.

The original data is available in the language of the country of manufacture.

Data source: Italian Medicines Agency (AIFA)

Data last verified: September 21, 2026